TB Researchers Revive Old Method In Search For New Drugs
Increasingly discouraged by genomics-based discovery, researchers revert to whole-cell screening for tuberculosis treatments
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
September 3, 2012 Cover
Volume 90, Issue 36
Increasingly discouraged by genomics-based discovery, researchers revert to whole-cell screening for tuberculosis treatments
Cover image:
Credit:
Increasingly discouraged by genomics-based discovery, researchers revert to whole-cell screening for tuberculosis treatments
FDA struggles to identify products, optimize review process
ACS Meeting News: With new methods to modify protein backbones, chemists probe what makes proteins stable
ACS Meeting News: Massive marine supply of metal drives researchers to design selective, durable sorbents
ACS Meeting News: Chemists discuss the growing role of natural products in developing new pesticides
Fee-for-service contracting rises in an opportunistic approach to drug discovery research
Chemical modifications allow single-stranded RNAs to silence genes via RNAi pathway